Section 0940-06-01-.03 - CONTROLLED SUBSTANCES IN SCHEDULE III(1) Schedule III consists of the drugs and other substances by whatever official name, common or usual name, chemical name, or brand name designated, listed in this rule. Each drug or substance bears the federal controlled substance code number assigned to it by the Drug Enforcement Administration.(2) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether optical, position or geometric), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:(a) Those compounds, mixtures, or preparations in dosage unit form containing any stimulant substances listed in Schedule II which compounds, mixtures, or preparations were listed on August 25, 1971, as excepted compounds under 21 C.F.R. 1308.32, and any other drug of the quantitative composition shown in that list for those drugs or which is the same except that it contains a lesser quantity of controlled substances .....................................1405(b) Benzphetamine ............................. 1228(c) Clorphentermine .............................1645(d) Clortermine ............................... 1647(e) Phendimetrazine .............................1615(3) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect in the central nervous system: (a) Any compound, mixture, or preparation containing:1. Amobarbital .............................. 21262. Secobarbital.............................. 23163. Pentobarbital.............................. 2271 Or any salt thereof and one or more other active medicinal ingredients which are not listed in any schedule.
(b) Any suppository dosage form containing: 1. Amobarbital .............................. 21262. Secobarbital.............................. 23163. Pentobarbital.............................. 2271 Or any salt of these drugs and approved by the Food and Drug Administration for marketing only as a suppository.
(c) Any substance which contains any quantity of a derivative of barbituric acid or any salt thereof. Examples include the following drugs................ 2100 1. Aprobarbital ............................... 21002. Butabarbital (secbutabarbital) ....................... 21003. Butalbital................................. 21004. Butobarbital (butethal) ........................... 21005. Talbutal................................. 21006. Thiamylal................................. 21007. Thiopental............................... 21008. Vinbarbital............................... 2100(d) Chlorhexadol................................. 2510(e) Embutramide................................. 2020(f) Gamma hydroxybutyric acid preparations. Any drug product containing gamma hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under § 505 of the federal Food, Drug, and Cosmetic Act, codified in 21 U.S.C. §§ 301, et seq........................ 2012(g) Ketamine, its salts, isomers, and salts of isomers ................7285 Other name: (±)-2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone
(h) Lysergic acid.................................. 7300(i) Lysergic acid amide.............................. 7310(j) Methyprylon................................. 2575(k) Perampanel, and its salts, isomers, and salts of isomers............. 2261(l) Sulfondiethylmethane.............................2600(m) Sulfonethylmethane............................... 2605(n) Sulfonmethane................................. 2610 (o) Tiletamine and zolazepam or any salt of tiletamine or zolazepam.......... 7295 1. Other name for a tiletamine-zolazepam combination product: Telazol®.2. Other name for tiletamine: 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.3. Other names for zolazepam: 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo[3,4-e],[1,4]-diazepin-7(1H)-one; flupyrazapon.(4) Nalorphine................................... 9400(5) Narcotic Drugs. (a) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any of the following narcotic drugs, or their salts calculated as the free anhydrous base or alkaloid, in limited quantities as set forth below: 1. Not more than 8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium............................ 98032. Not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts...................... 98043. Not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit with one or more active non-narcotic ingredients in recognized therapeutic amounts...................... 98074. Not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit with one or more active non-narcotic ingredients in recognized therapeutic amounts............... 98085. Not more than 500 milligrams of opium per 100 milliliters or per 100 grams or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic ingredients in recognized therapeutic amounts................. 98096. Not more than 50 milligrams of morphine per 100 milliliters or per 100 grams, with one or more active, non-narcotic ingredients in recognized therapeutic amounts.................................... 9810(b) Any material, compound, mixture, or preparation containing any of the following narcotic drugs or their salts: 1. Buprenorphine............................. 9064(6) Anabolic steroids. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing any quantity of the following substances, including its salts, esters and ethers: (a) Anabolic steroids.............................. 40001. 3[alpha],17[beta]-dihydroxy-5a-androstane2. 17[alpha]-methyl-3[alpha],17[beta]-dihydroxy-5a-androstane3. 17[alpha]-methyl-3[beta],17[beta]-dihydroxy-5a-androstane4. 17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-4-ene5. 17[alpha]-methyl-[delta]1-dihydrotestosterone(17[beta]-hydroxy-17[alpha]-methyl-5[alpha]- androst-1-en-3-one) Other name: 17-[alpha]-methyl-1-testosterone
6. 17[alpha]-methyl-4-hydroxynandrolone(17[alpha]-methyl-4-hydroxy-17[beta]-hydroxyestr-4-en-3-one)7. 1-Androstenediol (3[alpha],17[beta]-dihydroxy-5[alpha]-androst-1-ene)8. 1-Androstenediol (3[beta],17[beta]-dihydroxy-5[alpha]-androst-1-ene)9. 4-Androstenediol (3[beta],17[beta]-dihydroxy-androst-4-ene)10. 5-Androstenediol (3[beta],17[beta]-dihydroxy-androst-5-ene)11. 1-Androstenedione (5[alpha]-androst-1-en-3,17-dione)12. 4-Androstenedione (androst-4-en-3,17-dione)13. 5-Androstenedione (androst-5-en-3,17-dione)14. 3[Beta],17[Beta]-dihydroxy-5a-androstane15. 13[Beta]-ethyl-17[beta]-hydroxygon-4-en-3-one16. Androstanedione (5[alpha]-androstan-3,17-dione)17. Bolasterone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one)18. Boldenone (17[beta]-hydroxyandrost-1,4-diene-3-one)19. Boldione (androsta-1,4-diene-3,17-dione)20. Calusterone (7[beta],17[alpha]-dimethyl-17[beta]-hydroxyandrost-4-en-3-one)21. Clostebol (4-chloro-17[beta]-hydroxyandrost-4-en-3-one) Other name: 4-Chlorotestosterone
22. Dehydrochloromethyltestosterone (4-chloro-17[beta]-hydroxy-17[alpha]-methylandrost-1,4-dien-3- one)23. [Delta]1-dihydrotestosterone (a.k.a. '1-testosterone') (17[Beta]-hydroxy-5[alpha]-androst-1-en-3-one)24. Desoxymethyltestosterone (17[alpha]-methyl-5[alpha]-androst-2-en-17[Beta]-ol) Other name: madol
25. 4-Dihydrotestosterone (17[beta]-hydroxyandrostan-3-one)26. Drostanolone (17[beta]-hydroxy-2[alpha]-methyl-5[alpha]-androstan-3-one)27. Ethylestrenol (17[alpha]-ethyl-17[beta]-hydroxyestr-4-ene)28. Fluoxymesterone (9-fluoro-17[alpha]-methyl-11[beta],17[beta]-dihydroxyandrost-4-en-3-one)29. Formebolone (2-formyl-17[alpha]-methyl-11[alpha],17[beta]-dihydroxyandrost-1,4-dien-3-one)30. Furazabol (17[alpha]-methyl-17[beta]-hydroxyandrostano[2,3-c]-furazan)31. 4-Hydroxy-19-nortestosterone (4,17[beta]-dihydroxyestr-4-en-3-one)32. 4-Hydroxytestosterone (4,17[beta]-dihydroxyandrost-4-en-3-one)33. Mestanolone (17[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one)34. Mesterolone (1[alpha]-methyl-17[beta]-hydroxy-5[alpha]-androstan-3-one)35. Methandienone (17[alpha]-methyl-17[beta]-hydroxyandrost-1,4-diene-3-one)36. Methandriol (17[alpha]-methyl-3[beta],17[beta]-dihydroxyandrost-5-ene)37. Methasterone (2[alpha],17[alpha]-dimethyl-5[alpha]-androstan-17[beta]-ol-3-one)38. Methenolone (1-methyl-17[beta]-hydroxy-5[alpha]-androst-1-en-3-one)39. Methyldienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4,9(10)-dien-3-one)40. Methyltestosterone (17[alpha]-methyl-17[beta]-hydroxyandrost-4-en-3-one)41. Methyltrienolone (17[alpha]-methyl-17[beta]-hydroxyestra-4, 9,11-trien-3-one)42. Mibolerone (7[alpha],17[alpha]-dimethyl-17[beta]-hydroxyestr-4-en-3-one)43. Nandrolone (17[beta]-hydroxyestr-4-en-3-one)44. 19-Nor-4,9(10)-androstadienedione (estra-4,9(10)-diene-3,17-dione)45. 19-Nor-4-androstenediol (3[alpha],17[beta]-dihydroxyestr-4-ene)46. 19-Nor-4-androstenediol (3[beta],17[beta]-dihydroxyestr-4-ene)47. 19-Nor-5-androstenediol (3[alpha],17[beta]-dihydroxyestr-5-ene)48. 19-Nor-5-androstenediol (3[beta],17[beta]-dihydroxyestr-5-ene)49. 19-Nor-4-androstenedione (estr-4-en-3,17-dione)50. 19-Nor-5-androstenedione (estr-5-en-3,17-dione)51. Norbolethone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4-en-3-one)52. Norclostebol (4-chloro-17[beta]-hydroxyestr-4-en-3-one)53. Norethandrolone (17[alpha]-ethyl-17[beta]-hydroxyestr-4-en-3-one)54. Normethandrolone (17[alpha]-methyl-17[beta]-hydroxyestr-4-en-3-one)55. Oxandrolone (17[alpha]-methyl-17[beta]-hydroxy-2-oxa-5[alpha]-androstan-3-one)56. Oxymesterone (17[alpha]-methyl-4,17[beta]-dihydroxyandrost-4-en-3-one)57. Oxymetholone (17[alpha]-methyl-2-hydroxymethylene-17[beta]-hydroxy-[5[alpha]]-androstan-3-one)58. Prostanozol (17[beta]-hydroxy-5[alpha]-androstano[3,2-c]pryazole)59. Stanozolol (17[alpha]-methyl-17[beta]-hydroxy-[5[alpha]]-androst-2-eno[3,2-c]-pyrazole)60. Stenbolone (17[beta]-hydroxy-2-methyl-[5[alpha]]-androst-1-en-3-one)61. Testolactone (13-hydroxy-3-oxo-13,17-secoandrosta-1, 4-dien-17-oic acid lactone)62. Testosterone (17[beta]-hydroxyandrost-4-en-3-one)63. Tetrahydrogestrinone (13[beta],17[alpha]-diethyl-17[beta]-hydroxygon-4, 9,11-trien-3-one)64. Trenbolone (17[beta]-hydroxyestr-4,9,11-trien-3-one)(b) Any salt, ester, or isomer of a drug or substance described or listed in subparagraph (a), if such salt, ester, or isomer promotes muscle growth.(c) Anabolic steroids intended for administration to cattle or other non-human species are exempt from this rule unless such steroids are prescribed, dispensed, or distributed for human use.(d) Anabolic steroids with a combination of estrogens intended for administration to hormone deficient women are exempt from this rule unless such steroids are prescribed, dispensed, or distributed to women who are not hormone deficient.(7) Hallucinogenic Substances (a) Dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a United States Food and Drug Administration approved drug product...... 7369 Other names: (6aR-trans)-6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo [b,d]pyran-1-ol or (-)-delta-9-(trans) tetrahydrocannabinol
Tenn. Comp. R. & Regs. 0940-06-01-.03
Original rule filed April 29, 1981; effective June 18, 1981. Repeal and new rule filed May 25, 1984; effective June 24, 1984. Repeal and new rule filed September 6, 1985; effective October 10, 1985. Repeal and new rule filed December 17, 1986; effective January 31, 1987. Amendment filed July 10, 1997; effective September 23, 1997. Repeal and new rule filed January 7, 2011; effective April 7, 2011. Repeal and new rule filed December 20, 2013; effective March 20, 2014. Repeal and new rule filed February 24, 2015; effective May 25, 2015. Repeal and new rule filed March 4, 2016; effective June 2, 2016. Repeal and new rules filed March 21, 2017; effective June 19, 2017. Repeal and new rules filed July 5, 2018; effective October 3, 2018. Amendments filed September 24, 2021; effective December 23, 2021. Amendments filed March 1, 2024; effective 5/30/2024.Authority: T.C.A. §§ 4-4-103, 33-1-302, 33-1-303, 33-1-305, 33-1-309, and 39-17-403.